IMM
Click for more information
1.61% 31.5¢ immutep limited

BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's...

  1. tankhexman
    537 Posts.
    lightbulb Created with Sketch. 64
    clock Created with Sketch.
    05/10/24
    05:40
    Post #: 75988186
    BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda.

    Anther join the dots moment .
    IMM Price at posting: 31.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Regulatory approval granted for drilling at high-grade lead and silver project—drilling set to begin soon
right-arrow Created with Sketch.
NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS High-grade copper assays continue to impress—resource update coming soon
right-arrow Created with Sketch.
NEWS Large-scale copper discovery confirmed with high-grade assays—significant potential for major sedimentary-hosted copper deposits
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
31.5¢ 		Change
0.005(1.61%) 		Mkt cap ! $458.1M
Open High Low Value Volume
31.0¢ 31.5¢ 30.5¢ $251.5K 806.4K

Buyers (Bids)

No. Vol. Price($)
11 121215 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 2864 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.